Omipalisib

PI3K inhibitor

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Used to treat other disease

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Link	Tested on	Impact factor	Notes	Publication date
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication	CaCo-2 cells	15.58		Aug/11/2020

Link	Publication date
Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay	Sep/07/2021